Related Experiment Video
Updated: Jun 27, 2026

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
Prospects for immunotoxin therapy in cancer
Abstract:
Immunotoxins are formed by chemically linking antibodies to "toxic" polypeptides that inactivate protein synthesis. These hybrid protein molecules are guided to tumor cells by the antibody moiety, and once bound to the tumor cells, the toxic polypeptide moiety penetrates the cell membrane and enzymatically inactivates protein synthesis. A stepwise approach to identifying the potential clinical uses of immunotoxins in cancer therapy is examined in this chapter.
Insights
Immunotoxins, which link antibodies to toxic proteins, target cancer cells by inactivating protein synthesis. This chapter explores their potential clinical applications in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Immunotoxins are hybrid molecules combining antibody specificity with cytotoxic polypeptide activity.
- Antibodies direct immunotoxins to target cells, such as tumor cells.
- The cytotoxic moiety enters the target cell and inhibits protein synthesis, leading to cell death.
Purpose of the Study:
- To examine a stepwise approach for identifying potential clinical uses of immunotoxins.
- To explore the therapeutic potential of immunotoxins in cancer treatment.
Main Methods:
- The chapter reviews the mechanism of action of immunotoxins.
- It discusses the principles guiding the development and application of immunotoxins in a clinical setting.
Main Results:
- Immunotoxins offer a targeted approach to cancer therapy by selectively delivering cytotoxic payloads to tumor cells.
- The antibody component ensures specific binding to cancer cells, minimizing off-target effects.
Conclusions:
- Immunotoxins represent a promising strategy for cancer treatment due to their targeted mechanism.
- Further research and a systematic approach are necessary to fully realize their clinical potential in oncology.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

